Clinical features and predictors for patients with severe SARS-CoV-2 pneumonia at the start of the pandemic: a retrospective multicenter cohort study

Table 3 The risk factors in predicting patients with mild to moderate SARS-CoV-2 pneumonia conversion rate to severe cases

Variable	Regression coefficient	Standard error	P value	Odds ratio	Lower OR	Upper OR
Age, years	-0·04	0·04	0·2376	0·96	0·90	1·03
Gender (female vs. male)	−1·38	0·76	0·0702	0·25	0·06	1·12
Fever (yes vs. no)	1·13	0·60	0·0597	3·09	0·96	9·99
Comorbidities (yes vs. no)	0·87	0·86	0·3121	2·38	0·44	12·76
C-reactive protein (< 10 mg/L vs.≧10 mg/L)	0·38	0·75	0·6145	1·46	0·33	6·40
Lymphocyte count (per reduced 0·1 × 10⁹/L)	−0·25	0·09	0·0070	0·78	0·65	0·94
Time from onset of illness to antiviral treatment, days	0·03	0·06	0·6670	1·03	0·91	1·17
Corticosteroids (yes vs. no)	−1·99	0·90	0·0275	0·14	0·02	0·80

ISSN: 1471-2334